30 completed, 9 unknown, 8 terminated, 6 recruiting. 16 Phase 3, 16 Phase 4, 11 Phase 2, 7 Not applicable, 1 Early Phase 1.
Follow Tinzaparin: new trials by email Literature Review of Tinzaparin trials Research Report on Tinzaparin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial. Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity | Not applicable | Not yet recruiting | University College Dublin | 180 | 2026-08-01 | 2026-05-18 |
| The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Aspirin, Low-molecular-weight heparin - Venous Thromboembolism, Postpartum Period | Phase 3 | Recruiting | University of Calgary | 8805 | 2026-06-04 | 2026-07-27 |
| Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention rivaroxaban and ASA, Low-molecular weight heparin, Fondaparinux - Hip Fracture Surgery, Cardiovascular Prevention | Phase 3 | Not yet recruiting | McMaster University | 100 | 2025-12-01 | 2025-11-14 |
| THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium - Venous Thromboembolism, Varicose Veins | Phase 4 | Recruiting | Imperial College London | 3175 | 2024-01-22 | 2026-06-04 |
| TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer Tinzaparin - Colorectal Cancer Metastatic, Thromboembolism | Phase 3 | Completed | Galician Research Group on Digestive Tumors | 232 | 2023-03-02 | 2025-08-22 |
| LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention Aspirin, Tinzaparin - Preeclampsia Severe, Toxemia Of Pregnancy | Phase 4 | Recruiting | Alexandra Hospital, Athens, Greece | 100 | 2023-01-18 | 2026-01-23 |
| STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis Enoxaparin, Dalteparin, Tinzaparin - Cancer-associated Thrombosis, Thrombocytopenia | Phase 4 | Recruiting | Tzu-Fei Wang | 50 | 2022-08-29 | 2025-12-17 |
| Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer Tinzaparin Injectable Solution - Epithelial Ovarian Cancer | Phase 2 | Recruiting | University Hospital, Linkoeping | 40 | 2022-07-12 | 2026-05-11 |
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel - Pancreatic Cancer, Thromboembolism | Phase 3 | Unknown | Michalis Karamouzis | 450 | 2022-02-10 | 2022-03-29 |
| Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome tinzaparin, Rivaroxaban - Deep Vein Thrombosis, Post Thrombotic Syndrome | Phase 4 | Terminated | Sunnybrook Health Sciences Centre | 9 | 2021-11-15 | 2024-04-04 |
| Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients tinzaparin - Covid19, Hospitalization | Unknown | University Hospital of Patras | 300 | 2021-10-01 | 2021-09-08 | |
| ANTIcoagulation in Severe COVID-19 Patients Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose prophylactic anticoagulation, Tinzaparin,Therapeutic anticoagulation - Severe COVID-19 Pneumonia | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 353 | 2021-04-14 | 2022-09-08 |
| Pre- Vs Postoperative Thromboprophylaxis for Liver Resection enoxaparin or tinzaparin or dalteparin, No intervention - Liver Cancer, Surgery | Phase 4 | Recruiting | Helsinki University Central Hospital | 1012 | 2021-02-10 | 2025-02-14 |
| Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis Tinzaparin - Deep Vein Thrombosis, Inflammatory Response | Not applicable | Active not recruiting | Centre Hospitalier Universitaire, Amiens | 9 | 2021-02-02 | 2025-05-29 |
| Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID) Tinzaparin - Covid19, Thrombosis | Not applicable | Completed | Hospital Universitario Infanta Leonor | 311 | 2021-02-01 | 2022-09-15 |
| Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE theraputic heparin, prophylactic heparin, P2Y12 - Covid19 | Phase 4 | Completed | Matthew Neal MD | 3591 | 2020-09-04 | 2024-12-30 |
| Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial (Arm Closed) Nafamostat Mesilate, (Arm Closed) Enoxaparin, (Arm Closed) Dalteparin - SARS-CoV-2 Infection (COVID-19) | Phase 3 | Unknown | University of Melbourne | 2200 | 2020-07-28 | 2024-05-16 |
| Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 Enoxaparin - COVID, Thrombosis | Phase 4 | Completed | Central Hospital, Nancy, France | 1000 | 2020-05-13 | 2023-08-07 |
| Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort Tinzaparin or unfractionated heparin - COVID19 Pneumonia | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 808 | 2020-04-20 | 2020-04-15 |
| Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients Dose of tinzaparin or dalteparin - Covid19, Thromboembolism | Completed | Karolinska Institutet | 257 | 2020-03-01 | 2023-05-31 |
Showing 20 of 56. Sign in to see all of them.
Venous Thromboembolism (18) · Venous Thrombosis (18) · Pulmonary Embolism (11) · Thromboembolism (8) · COVID-19 (6) · Neoplasms (6) · Thrombosis (6) · Hemorrhage (4) · Kidney Failure, Chronic (3) · Lung Neoplasms (3) · Colorectal Neoplasms (2) · Fetal Growth Retardation (2) · Ischemic Stroke (2) · Lymphoma (2) · Multiple Myeloma (2)
Assistance Publique - Hôpitaux de Paris (5) · Ottawa Hospital Research Institute (5) · University of Calgary (4) · LEO Pharma (3) · Aalborg University Hospital (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ain Shams University (1) · Alexandra Hospital, Athens, Greece (1) · Cardiff University (1) · Central Hospital, Nancy, France (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Centre Hospitalier Universitaire, Amiens (1) · Christine Ribic (1) · Complejo Hospitalario Xeral-Calde (1) · Duke University (1)
Canada (20) · France (14) · Spain (8) · United States (8) · Denmark (5) · Italy (4) · Netherlands (4) · Belgium (3) · Germany (3) · Greece (3) · Ireland (3) · Egypt (2) · Norway (2) · Poland (2) · Sweden (2)
Marc Rodger, MD (3) · Guy Meyer, MD (2) · Leslie Skeith, MD (2) · Marc Carrier, MD (2) · Russell D Hull, MBBS, MSc (2) · Agnes Y. Y. Lee, MD, MSc, FRCPC (1) · Alain Leizorovicz, MD (1) · Alejandro Veres Racamonde, MD (1) · Anna Karlsson, MD (1) · Anna-Clara Spetz Holm, MD, PhD (1) · Anne-Mette Hvas, PhD, professor (1) · Antoni Romera, MD (1) · Armand Mekontso Dessap, MD, PhD (1)
PMID 33502773, PMID 33779986, PMID 32358837, PMID 35244208, PMID 38189593, PMID 11867132, PMID 14987333, PMID 15302749, PMID 16458642, PMID 18086925, PMID 19036065, PMID 19458109, PMID 20332509, PMID 20622663, PMID 21477846, PMID 22315264, PMID 23245654, PMID 23303884, PMID 23764005, PMID 24141714, PMID 24768093, PMID 25903529, PMID 26284719, PMID 26490434, PMID 26810338, PMID 26868660, PMID 28930514, PMID 29618162, PMID 30121858, PMID 30262574, PMID 31116676, PMID 31986264, PMID 32202076, PMID 33337539, PMID 34473343, PMID 34875111, PMID 34878173, PMID 34896011, PMID 34953516, PMID 35473740, PMID 36100263, PMID 36233500, PMID 36354038, PMID 36514143, PMID 36695396, PMID 36942550, PMID 36946232, PMID 37227729, PMID 37350990, PMID 37356038
1OT2HL156812-01 (1), 2009 (1), 2014 (1), 2016 (1)